Key Roles of MiT Transcription Factors in Innate Immunity and Inflammation
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Irazoqui, Javier E.UMass Chan Affiliations
Program in Innate ImmunityDepartment of Microbiology and Physiological Systems
Document Type
Journal ArticlePublication Date
2020-02-01Keywords
TFEBTFE3
transcription
inflammation
innate immunity
infection
Immunology and Infectious Disease
Microbiology
Metadata
Show full item recordAbstract
Microphthalmia/TFE (MiT) transcription factors (TFs), such as transcription factor EB (TFEB) and transcription factor E3 (TFE3), are emerging as key regulators of innate immunity and inflammation. Rapid progress in the field requires a focused update on the latest advances. Recent studies show that TFEB and TFE3 function in innate immune cells to regulate antibacterial and antiviral responses downstream of phagocytosis, interferon (IFN)-gamma, lipopolysaccharide (LPS), and adenosine receptors. Moreover, overexpression of TFEB or TFE3 can drive inflammation in vivo, such as in atherosclerosis, while in other scenarios they can perform anti-inflammatory functions. MiT factors may constitute potential therapeutic targets for a broad range of diseases; however, to harness their therapeutic potential, sophisticated ways to manipulate MiT factor activity safely and effectively must be developed.Source
Trends Immunol. 2020 Feb;41(2):157-171. doi: 10.1016/j.it.2019.12.003. Epub 2020 Jan 17. Link to article on publisher's site
DOI
10.1016/j.it.2019.12.003Permanent Link to this Item
http://hdl.handle.net/20.500.14038/36508PubMed ID
31959514Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.it.2019.12.003